Devicare and Idneo, a CataloniaBio & HealthTech members, han signat signed a strategic collaboration to develop and manufacture self-testing diagnostic devices.
Devicare will transfer the manufacturing of the Lit-Control® pH Meter device to Idneo. Furthermore, both companies will cooperate in the development of enhanced versions of the device.
“This agreement will allow our company to scale its manufacturing capabilities and engineering resources with the aim to offer the most reliable technology to our customers, doctors and patients" says Rosendo Garganta, CEO of Devicare.
Patients and doctors use the Lit-Control® pH Meter to periodically measure, in a simple and quick way, the pH of the urine in order to prevent the formation of kidney stones.
Devicare has validated the Lit-Control®’s usability and efficacy in different clinical trials published in 15 scientific articles and has signed almost 50 distribution agreements around the world.
Photo: From left to right, Rosendo Garganta with Pau Planas, director of Idneo MedTech Business Unit.
Comments